Ultragenyx Pharmaceutical RARE
NASDAQ RARE
$15.23 +0.48 (+3.25%)
As of: Oct 2, 2026 · 3:44 PM EDT

Ultragenyx Pharmaceutical (RARE) Other Operating Expenses (2017 - 2026)

Updated

Ultragenyx Pharmaceutical (RARE) recorded Other Operating Expenses of $34 million in Q2 2026, up 47.8% from $23 million a year earlier and up 13.3% from the prior quarter.

Analysis

Ultragenyx Pharmaceutical (RARE) Other Operating Expenses (2017 - 2026) Analysis & Trends

On a TTM basis, Ultragenyx Pharmaceutical's Other Operating Expenses came in at $121.34 million as of Jun 30, 2026, up 34.5% year-over-year; for FY2025, it came in at $109 million, up 41.6% from FY2024.

  • Annual Other Operating Expenses has increased for five straight years, with a five-year compound annual growth rate of 77.8% (FY2020 to FY2025).
  • Across earlier years, Other Operating Expenses came in at $77 million in FY2024 (+71.1%), $45 million in FY2023 (+58.9%), $28.32 million in FY2022 (+76.9%) and $16.01 million in FY2021 (+161.2%).
  • The Q2 2026 figure is the highest quarterly Other Operating Expenses in data going back to Q4 2017.
  • On a year-over-year basis, Other Operating Expenses has increased for 18 consecutive quarters, with growth averaging 45.6% over the last eight quarters.
  • Peak year-over-year performance for Other Operating Expenses in the last five years was growth of 163.7% in Q2 2022, against a decline of 36.0% in Q4 2021 at the low end.
  • Per Business Quant, the preceding three quarters came in at $30 million (Q1 2026), $29.35 million (Q4 2025) and $27.99 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Ultragenyx Pharmaceutical 1.48 Bn -321.29 Mn 180.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 34.00 Mn
Mar 31, 2026 30.00 Mn
Dec 31, 2025 29.35 Mn
Sep 30, 2025 27.99 Mn
Jun 30, 2025 23.00 Mn
Mar 31, 2025 29.00 Mn
Dec 31, 2024 17.17 Mn
Sep 30, 2024 21.02 Mn
Jun 30, 2024 21.28 Mn
Mar 31, 2024 17.53 Mn
Dec 31, 2023 11.84 Mn
Sep 30, 2023 10.99 Mn
Jun 30, 2023 9.91 Mn
Mar 31, 2023 12.26 Mn
Dec 31, 2022 5.32 Mn
Sep 30, 2022 8.63 Mn
Jun 30, 2022 8.27 Mn
Mar 31, 2022 6.10 Mn
Dec 31, 2021 3.51 Mn
Sep 30, 2021 4.18 Mn
API Access

Ultragenyx Pharmaceutical Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=RARE&period=max&api_key=YOUR_API_KEY